KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Common Equity (2016 - 2025)

Medpace Holdings' Common Equity history spans 11 years, with the latest figure at $459.1 million for Q4 2025.

  • For Q4 2025, Common Equity fell 44.39% year-over-year to $459.1 million; the TTM value through Dec 2025 reached $459.1 million, down 44.39%, while the annual FY2025 figure was $459.1 million, 44.39% down from the prior year.
  • Common Equity reached $459.1 million in Q4 2025 per MEDP's latest filing, up from $293.6 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $952.9 million in Q4 2021 to a low of $172.4 million in Q2 2025.
  • Average Common Equity over 5 years is $580.8 million, with a median of $576.3 million recorded in 2023.
  • Peak YoY movement for Common Equity: skyrocketed 95.26% in 2024, then tumbled 77.43% in 2025.
  • A 5-year view of Common Equity shows it stood at $952.9 million in 2021, then crashed by 59.45% to $386.4 million in 2022, then surged by 44.66% to $558.9 million in 2023, then surged by 47.7% to $825.5 million in 2024, then tumbled by 44.39% to $459.1 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Common Equity are $459.1 million (Q4 2025), $293.6 million (Q3 2025), and $172.4 million (Q2 2025).